Outcome of Board Meeting

Ref. No.: QHTL/Sec/SE/2026-27/21 July 30, 2026 To, To, The Manager, The Manager, Corporate Services, Corporate Services, BSE Limited, National Stock Exchange of India Limited, 14th Floor, P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Security ID: QUICKHEAL Symbol: QUICKHEAL Security Code: 539678 Series: EQ Subject: Outcome of Board Meeting held on July 30, 2026. Dear Sir / Madam, Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its meeting held on July 30, 2026, which commenced at 05:30 PM IST and concluded at 8:30 PM IST, has approved following: 1. Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended June 30, 2026. 2. M S K A & Associates LLP, Chartered Accountants, Statutory Auditors of the Company, have issued a Limited Review Report with an unmodified opinion on the above-mentioned results. 3. Based on the recommenda(cid:415)on of Nomina(cid:415)on and Remunera(cid:415)on Commi(cid:425)ee, the Board considered and proposed the re-appointment of Mr. Richard S(cid:415)ennon (DIN: 09324046) as Non-Execu(cid:415)ve Independent Director of the Company for a second term of 5 consecu(cid:415)ve years w.e.f. September 27, 2026, for approval of the shareholders at the ensuing Annual General Mee(cid:415)ng. The details are enclosed as Annexure A. 4. Shifting of the Registered Office of the Company within the same city limit from Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Opposite Neco Garden Society, Viman Nagar, Pune – 411014 to S. No. 1442-1445, Thube Park, Shivajinagar, Pune – 411005, with effect from July, 30, 2026 5. Books of Accounts are kept at the Corporate Office situated at 3rd and 4th Floor, Indiqube Orchid, Shastrinagar, Yerwada, Pune - 411006 with effect from July, 30, 2026. A copy of the Press Release and Investor Presentation in respect of the aforesaid Financial Results are enclosed herewith. This is for your information and records. For Quick Heal Technologies Limited Vikram Dhanani Compliance Officer ANNEXURE A Sr. No. Details of Event that needs to be provided Information of such events 1 Name of the Director / KMP / Senior Mr. Richard Stiennon Management 2 Reason for change viz appointment, Re-appointment as Non-Executive reappointment, resignation, removal, death Independent Director, subject to or otherwise approval of the shareholders at the ensuing Annual General Meeting. 3 Date of appointment / reappointment / Re-appointment for a second term of 5 cessation (as applicable) & term of consecutive years with effect from appointment/ re-appointment) September 27, 2026, to September 26, 2031. 4 Brief Profile (in case of appointment) Mr. Richard Stiennon has over 30 years of rich experience across the industry, Mr. Richard Stiennon is one of the most renowned analysts and thought leaders in the global cybersecurity industry. During his career, he had advised the executive teams and boards at some of the biggest cybersecurity companies, including Symantec, McAfee, Cisco, Microsoft and Trend Micro. In his previous stints, he has held senior leadership positions at Gartner, PwC, Webroot Software, Fortinet, and Blancco Technology Group. He was an advisor on the Extreme Cyber Advisory Panel for Commonwealth Bank in Australia. Additionally, he had provided due diligence for several M&A deals including the acquisition of Trustwave by Singtel. 5 Disclosure of relationships between Mr. Richard Stiennon is not related to directors (in case of appointment of a any Director of the Company. director) 6 Information as required under BSE circular Mr. Richard Stiennon is not debarred Number LIST/COM/14/2018-19 and NSE from accessing the capital markets circular no. NSE/CML/2018/24 dated 20th and/or restrained from holding the June, 2018 position of Director in any listed Company by virtue of any order of the Securities and Exchange Board of India or any other such authority. 7 Letter of resignation along with detailed Not Applicable reason for resignation 8 Names of listed entities in which the Not Applicable resigning Independent Director holds directorships, indicating the category of directorship and membership of board committees, if any. 9 The independent director shall, along with Not Applicable the detailed reasons, also provide a confirmation that there is no other material reasons other than those provided. 10 Confirmation in compliance with SEBI Letter Mr. Richard Stiennon is not debarred dated June 14, 2018 read along with from holding office by virtue of SEBI Exchange Circular dated June 20, 2018 Order. (Affirmation that the person proposed to be appointed as Director is not debarred from holding the office by virtue of any SEBI Order or any other authority) Quick Heal Technologies Limited Reports Q1 FY27 Results Pune, 30th July 2026: Quick Heal Technologies Limited, a global provider of cybersecurity solutions, today announced its unaudited financial results for the quarter ended June 30, 2026. Key Financial Highlights Particulars (₹ Cr) Q1 FY26 Q4 FY26 Q1 FY27 Revenue 57.2 48.7 45.0 EBITDA (9.7) (29.3) (17.6) EBITDA Margin (17.0%) (60.2%) (39.1%) PAT (5.5) (19.9) (5.3) PAT Margin (9.6%) (40.9%) (11.7%) Harish Kumar G S, Chief Executive Officer, Quick Heal Technologies Limited, said: "We are executing against a clear growth agenda centred on AI-driven cybersecurity, exploring newer offerings, enterprise expansion, and customer-centric innovation. Our priority is to sharpen our go-to-market motion, elevate execution excellence, and enhance agility across the organisation to deliver greater customer value. By combining innovation with disciplined execution, we are strengthening our market position, deepening customer relationships, and building the capabilities required for sustainable long-term growth." Ankit Maheshwari, Chief Financial Officer, Quick Heal Technologies Limited, added: "We continue to maintain a disciplined approach to growth, balancing strategic investments with a strong focus on cash flows and operational efficiency. While consumer demand remains impacted by market headwinds, our focused collections strategy and prudent financial management have helped strengthen business fundamentals. In enterprise, we continue to see encouraging traction, supported by customer wins across high-priority sectors, including Defence, BFSI and IT services. These engagements reinforce our confidence in the market opportunity ahead and our ability to deliver sustainable growth through sharpened execution and customer-centric innovation." Strategic Highlights of Q1 FY27 include: • Appointed Harish Kumar G S as the Chief Executive Officer. • Secured a new patent for advanced Network Access Control (NAC) technology. • Joined forces with JISA Softech to strengthen enterprise DPDP compliance through integrated privacy technology. • Awarded a multi-year order to secure 1.5 lakh devices from Defence sector. • Added a significant Seqrite XDR customer in the banking technology sector, reinforcing momentum in critical industries • Awarded an order from one of the largest IT services companies, for our Threat intelligence offering • Consumer vertical continued to face market headwinds, with focused efforts on partner credit control. • Seqrite Labs uncovered Operation XENOFISCAL, exposing a Pakistan-linked SideCopy Group deploying persistent XenoRAT against Afghanistan's Ministry of Finance. As the Company progresses through FY27, it will continue to focus on strengthening its cybersecurity portfolio and delivering value to customers across consumer and enterprise businesses. About Quick Heal Technologies Limited Quick Heal Technologies Limited is a leading global cybersecurity solutions provider. Incorporated in 1995 with a registered office in Pune, it offers end-to-end cybersecurity solutions across B2C, B2B, a [Showing first 8,000 characters — download PDF for full document]